Institutional Biosafety Committee (IBC)
We are working remotely and cannot accept paper copies. Please submit all protocols/amendments via email.
IBC Authority and Purpose
The University of North Dakota Institutional Biosafety Committee (IBC) requires that any biological research or teaching activities, particularly those utilizing DNA, recombinant DNA, transgenic organisms, or biohazardous research material, be subject to a University Review Process and that these activities must be approved by the IBC prior to their initiation.
The IBC is the only authorized University committee that can give approval to projects and activities involving DNA, recombinant DNA and biohazardous research material.
The IBC will follow UND laboratory biosafety guidelines and the NIH guidelines for DNA, recombinant DNA and biohazardous material research in determining the suitability of projects and activities. For any proposed activity not approved by the IBC, an explanation of that decision will be provided. Any project or activity not approved can be revised and resubmitted to the IBC for consideration.
IBC Application Process
All faculty or staff who plan on using recombinant DNA, biohazardous materials or conducting activities that involve the handling of biological materials in a research setting (live or dead animals, plant or animal pathogens, tissue, blood, bodily secretions, nucleic acids, toxins, etc.), teaching, or other activities must submit a completed, signed application form via email to the Office of Research Compliance & Ethics at UND.ibc@UND.edu.
One copy of all funded grant applications utilizing recombinant DNA or biohazardous materials must be submitted to the IBC with the application. The PI will not be able to access grant funds or begin the project until the IBC has reviewed and approved the project.
All approved projects must be reviewed on an annual basis, and any changes to an approved project must receive IBC approval prior to their implementation.
Meetings are held at 2:00 p.m. on the first Wednesday of each month and will be held virtually until further notice. All new submissions and 3-year renewals must be submitted by the meeting deadline indicated below:
|Meeting Date||Protocol Submission Deadline|
|September 1, 2021||
August 15, 2021
|October 6, 2021||
September 15, 2021
|November 3, 2021||
October 15, 2021
|December 1, 2021||
November 15, 2021
|January 5, 2022||
December 15, 2021
|February 2, 2022||
January 15, 2022
|March 2, 2022||
February 15, 2022
|April 6, 2022||
March 15, 2022
|May 4, 2022||
April 15, 2022
|June 1, 2022||
May 15, 2022
|Name||Term Start Date||Highest Degree||Scientific Specialty||Affiliation with UND|
|Michelle Bowles4||Ex Officio||M.P.A., CIP
||Regulatory compliance & research ethics
||Director of Research Assurance & Ethics
|David Bradley||5/5/08||Ph.D.||Microbiology||Associate Professor, Biomedical Sciences
|Catherine Brissette2||11/1/17||Ph.D.||Lyme disease, spirochetes, bacterial pathogenesis||Associate Professor, Biomedical Sciences catherine.brissette@UND.edu|
|Scott Garrett||4/5/05||Ph.D.||Pathology||Associate Professor, Pathology
|Marcus Lee3||3/1/20||Emergency Preparedness||Community Member, Grand Forks Public Health email@example.com|
|Matthew L. Nilles1||11/15/01||Ph.D.||Microbiology; Bacterial Pathogenesis||Associate Professor, Biomedical Sciences
|Linda M. Ray||8/25/97||M.L.S.||Clinical Laboratory Science||Assistant Professor, Medical Laboratory Science
|MariJo Roiko3||4/15/20||Ph.D., D(ABMM)||Microbiology; Immunology||
Community Member, Altru Health System firstname.lastname@example.org
|Jefferson A. Vaughan||5/14/03||Ph.D.||Medical Entomology and Vector-Borne Diseases||Professor, Biology
||Biological Safety Officer
|Min Wu||5/1/11||M.D., Ph.D.||Infection and Immunity Cell and Molecular Biology, Nanomedicine||Professor, Biomedical Sciences
|Terry Wynne||3/1/14||B.A.||Campus Safety & Security||Associate Director for Safety
- IBC Research Registration Application: To be completed by all investigators conducting biological research.
- IBC Instructional Registration Application: To be completed by anyone using biological materials for educational or instructional purposes.
- IBC Protocol Change and Annual Review Form: To be completed annually by all investigators conducting biological research or when initiating a change to an approved IBC protocol.
- IBC Adverse Event Reporting Form: To be completed within 24 hours of an adverse event occurring on an approved IBC protocol.
Risk Assessment Resources
Material Transfer Agreements (MTA)
Material Transfer Agreements for biological materials are handled via a joint review process involving the IBC and the Office of Corporate Engagement & Commercializaton. Please visit Corporate Engagement & Commercialization for more information.
- Institutional Biological Safety Policy
- Bloodborne Pathogens Exposure Control Plan
- Sharps Policy
- Occupational Health Plan
- Respiratory Protection Plan
- Biological Safety Cabinet Policy
- Transport of Hazardous Materials Policy
Bloodborne Pathogens Training
Who Needs to Complete this Training?
Bloodborne pathogens training is mandatory for all laboratory investigators working with exposed blood, blood components, or any unfixed human tissue; and for other employees whose job responsibilities may expose them to such materials.
Any person who handles blood or certain other body fluids as part of their job, or whose job responsibilities include activities that might expose them to such body fluids is required to understand the potential hazards of such exposure and receive bloodborne pathogens training.